Catalyst Wire Dossier Catalyst Wire Dossier

Tamibarotene (OAM80)

tamibarotene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tamibarotene (OAM80), covering 2011-07-22 to 2011-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease [Phase 2]

See pricing